Recommended composition of influenza virus vaccines for use in the 2017–2018 northern hemisphere influenza season
Wkly Epidemiol Rec. 2017 Mar 17;92(11):117-28.
[Article in
English,
French]
No abstract available
MeSH terms
-
Animals
-
Antibodies, Viral / blood
-
Antiviral Agents / pharmacology
-
Enzyme Inhibitors / pharmacology
-
Geography, Medical
-
Global Health / statistics & numerical data
-
Humans
-
Influenza A Virus, H1N1 Subtype / drug effects
-
Influenza A Virus, H1N1 Subtype / genetics
-
Influenza A Virus, H1N1 Subtype / immunology
-
Influenza A Virus, H3N2 Subtype / drug effects
-
Influenza A Virus, H3N2 Subtype / genetics
-
Influenza A Virus, H3N2 Subtype / immunology
-
Influenza B virus / drug effects
-
Influenza B virus / genetics
-
Influenza B virus / immunology
-
Influenza Vaccines / immunology*
-
Influenza, Human / epidemiology
-
Influenza, Human / prevention & control*
-
Influenza, Human / virology*
-
Neuraminidase / antagonists & inhibitors
-
Seasons*
-
Zoonoses / epidemiology
-
Zoonoses / virology
Substances
-
Antibodies, Viral
-
Antiviral Agents
-
Enzyme Inhibitors
-
Influenza Vaccines
-
Neuraminidase